Sorrento Therape
SRNE
$0.00+0.00%
Delayed · as of Sep 22, 2026, 12:30 PM ET
Mkt cap
$385,896
EV/Sales
0.19
P/E ratio
N/A
FY2022 Revenue
$62.84M
EPS (FY2022)
$-1.37
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
-911.60%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
Latest reported SRNE revenue for 2022-12-31 was $62.8M. Net income was -$572.8M. Revenue was down 48.5% from 2017-09-30 to 2022-12-31. SRNE currently screens at market cap $385.9K.
Use this SRNE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SRNE income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Sorrento Therape (SRNE) is a biotechnology company in the Healthcare sector.
Latest cached Sorrento Therape (SRNE) revenue for Dec 31, 2022 was $62.8M. Net income was -$572.8M. Statements: https://lician.com/financials/srne
Sorrento Therape (SRNE) market capitalization is $385.9K on the latest cached snapshot.
Sorrento Therape (SRNE) cached previous close $0.00; day range $0.00 – $0.01; volume 501,682. Session quote: https://lician.com/quote/srne